查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968031

Yell老年诊断全球市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Yersinia Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

Yer Senior诊断市场预计将从2025年的42.2亿美元成长到2034年的64.3亿美元，2026年至2034年的复合年增长率为4.79%。

由于耶尔森菌属（尤其是小肠结肠炎耶尔森菌）引起的食源性疾病数量不断增加，全球耶尔森菌诊断市场正蓬勃发展。人们对细菌性胃肠道感染疾病的认识不断提高，以及监测系统的完善，都促进了诊断检测率的上升。此外，与受污染食品和水源相关的病例数量不断增加，也进一步推动了准确、快速诊断解决方案的需求。

分子诊断技术的进步，包括基于PCR的检测和快速免疫检测，是成长要素。医院和诊断检查室越来越多地采用自动化系统，以实现更快、更准确的检测。各国政府加强食品安全法规和疾病监测计画的倡议，也促进了已开发国家和开发中国家的市场扩张。

未来几年，就地检验和多重诊断平台技术的进步预计将对市场产生积极影响。数位健康技术与检查室自动化的整合将提高效率并加快检测结果的出具。公共卫生基础设施和感染疾病研究投入的增加将进一步加速市场成长，预计老年诊断市场将继续稳定扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球老年诊断市场：依检测方法划分

  • 市场分析、洞察与预测
  • 粪便培养
  • ELISA
  • 免疫测量
  • 试管凝集法
  • 电脑断层扫描
  • 超音波检查
  • 大肠镜检查

第五章：全球 Yell 老年诊断市场：依技术划分

  • 市场分析、洞察与预测
  • PCR
  • DNA探针
  • 单株抗体
  • 免疫检测
  • IT
  • 其他的

第六章：全球 Yell 老年诊断市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Gen-Probe
    • Bio-Rad
    • Affymetrix Inc
    • Abbott Laboratories
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Qiagen
    • Becton Dickinson
    • Hologic Inc
    • PerkinElmer
简介目录
Product Code: VMR112110054

The Yersinia Diagnostics Market size is expected to reach USD 6.43 Billion in 2034 from USD 4.22 Billion (2025) growing at a CAGR of 4.79% during 2026-2034.

The Global Yersinia Diagnostics Market is gaining momentum due to the rising prevalence of foodborne infections caused by Yersinia species, particularly Yersinia enterocolitica. Growing awareness about bacterial gastrointestinal infections and improved surveillance systems are contributing to higher diagnostic testing rates. Increasing cases linked to contaminated food and water supplies are further driving demand for accurate and rapid diagnostic solutions.

Technological advancements in molecular diagnostics, including PCR-based testing and rapid immunoassays, are key growth drivers. Hospitals and diagnostic laboratories are adopting automated systems for faster and more precise detection. Government initiatives aimed at strengthening food safety regulations and disease monitoring programs are also supporting market expansion across both developed and developing countries.

In the coming years, the market is expected to benefit from advancements in point-of-care testing and multiplex diagnostic platforms. Integration of digital health technologies and laboratory automation will improve efficiency and turnaround times. Rising investments in public health infrastructure and infectious disease research will further accelerate growth, positioning the Yersinia diagnostics market for steady expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Types

  • Stool Culture
  • ELISA
  • Radioimmunoassay
  • Tube Agglutination
  • CT Scan
  • Ultrasonography
  • Colonoscopy

By Techniques

  • PCR
  • DNA Probes
  • Monoclonal Antibodies
  • Immunoassay
  • IT
  • Others

COMPANIES PROFILED

  • GenProbe, BioRad, Affymetrix Inc, Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Becton Dickinson, Hologic Inc, PerkinElmer
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY TEST TYPES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Types
  • 4.2. Stool Culture Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Radioimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Tube Agglutination Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Ultrasonography Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Colonoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY TECHNIQUES 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Techniques
  • 5.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. DNA Probes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. IT Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Types
    • 6.2.2 By Techniques
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Types
    • 6.3.2 By Techniques
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Types
    • 6.4.2 By Techniques
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Types
    • 6.5.2 By Techniques
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Types
    • 6.6.2 By Techniques
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL YERSINIA DIAGNOSTICS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Gen-Probe
    • 8.2.2 Bio-Rad
    • 8.2.3 Affymetrix Inc
    • 8.2.4 Abbott Laboratories
    • 8.2.5 Roche Diagnostics
    • 8.2.6 Thermo Fisher Scientific
    • 8.2.7 Qiagen
    • 8.2.8 Becton Dickinson
    • 8.2.9 Hologic Inc
    • 8.2.10 PerkinElmer